Zoology · Ch 10 — Applications of Biotechnology
Biosafety Guidelines
Biosafety Guidelines
Concern over GMOs prompted the World Health Organization to set up an informal working group on biosafety in 1991, which produced a voluntary code of practice for releasing organisms into the environment; the International Centre for Genetic Engineering and Biotechnology (ICGEB) has since played a significant international role on biosafety and on the environmentally sustainable use of biotechnology, publishing guidance on the main areas of concern — risk to human health, to the environment, and to agriculture. In India, the Department of Biotechnology (DBT) developed its own rDNA safety guidelines under powers granted by the Environmental Protection Act, 1986, covering the manufacture, use, import, export and storage of hazardous microorganisms and genetically engineered organisms and cells. These guidelines are implemented and monitored on the ground by the same institutional chain used for approvals — the Institutional Biosafety Committees (IBSCs), the Review Committee on Genetic Manipulation (RCGM) and the Genetic Engineering Approval Committee (GEAC) under the …
What this figure shows. An infographic grouping GMO risks under three headings. Environmental: toxins produced by pest-resistant GMOs could harm non-target organisms and disrupt ecosystems; biodiversity could suffer from the destruction of pests, weeds and even competing plants; transferred genes could mutate and create unexpected new risks. Health: proteins expressed from transferred genes could trigger allergic reactions in humans or animals, a risk compounded because GM foods are not currently properly labelled. Agricultural: pest toxins in GM crops could drive the evolution of resistant pest populations; cross-species pollination could spread herbicide-resistance genes and create 'super-weeds'; antibiotic-resistance marker genes used during gene transfer could spread to pathogenic bacteria; and large biotech companies holding monopolistic patents over GM seeds raises an access/equity concern alongside the biological ones. The figure no …